$CCRD
CoreCard Corp

2019 Q4 Form 10-K Financial Statement

#000143774921004982 Filed on March 04, 2021

View on sec.gov

Income Statement

Concept 2019 Q4 2019 2018 Q4
Revenue $10.30M $34.30M $6.050M
YoY Change 70.25% 70.66% 137.25%
Cost Of Revenue $3.310M $11.76M $2.420M
YoY Change 36.78% 37.95% 69.23%
Gross Profit $6.990M $22.54M $3.640M
YoY Change 92.03% 94.75% 227.93%
Gross Profit Margin 67.86% 65.72% 60.17%
Selling, General & Admin $1.130M $3.646M $480.0K
YoY Change 135.42% 75.2% 17.07%
% of Gross Profit 16.17% 16.17% 13.19%
Research & Development $1.880M $5.516M $890.0K
YoY Change 111.24% 64.51% -36.88%
% of Gross Profit 26.9% 24.47% 24.45%
Depreciation & Amortization $280.0K $1.012M $180.0K
YoY Change 55.56% 64.82% 100.0%
% of Gross Profit 4.01% 4.49% 4.95%
Operating Expenses $3.010M $9.162M $1.370M
YoY Change 119.71% 68.61% 1612.5%
Operating Profit $3.980M $13.38M $2.270M
YoY Change 75.33% 117.88% 120.39%
Interest Expense
YoY Change
% of Operating Profit
Other Income/Expense, Net -$150.0K $99.00K $340.0K
YoY Change -144.12% -78.89% -120.24%
Pretax Income $3.860M $13.52M $2.250M
YoY Change 71.56% 116.31% -451.56%
Income Tax $170.0K $2.546M -$180.0K
% Of Pretax Income 4.4% 18.84% -8.0%
Net Earnings $3.700M $10.97M $2.430M
YoY Change 52.26% 75.67% -473.85%
Net Earnings / Revenue 35.92% 31.98% 40.17%
Basic Earnings Per Share $1.24
Diluted Earnings Per Share $0.41 $1.22 $0.27
COMMON SHARES
Basic Shares Outstanding 8.873M
Diluted Shares Outstanding 8.968M

Balance Sheet

Concept 2019 Q4 2019 2018 Q4
SHORT-TERM ASSETS
Cash & Short-Term Investments $26.42M $26.42M $19.27M
YoY Change 37.12% 37.09% 33.23%
Cash & Equivalents $26.42M $18.92M
Short-Term Investments $0.00 $0.00 $349.0K
Other Short-Term Assets $905.0K $905.0K $1.202M
YoY Change -24.71% -24.71% -49.35%
Inventory
Prepaid Expenses
Receivables $8.759M $8.759M $3.731M
Other Receivables $0.00 $0.00 $580.0K
Total Short-Term Assets $36.08M $36.08M $24.78M
YoY Change 45.59% 45.59% 37.23%
LONG-TERM ASSETS
Property, Plant & Equipment $2.177M $3.122M $1.513M
YoY Change 43.89% 106.35% 19.89%
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments $3.080M $3.081M $760.0K
YoY Change 305.26% 305.39% -26.92%
Other Assets $1.108M $163.0K $504.0K
YoY Change 119.84% -67.66% 191.33%
Total Long-Term Assets $8.161M $8.161M $4.522M
YoY Change 80.47% 80.47% 21.56%
TOTAL ASSETS
Total Short-Term Assets $36.08M $36.08M $24.78M
Total Long-Term Assets $8.161M $8.161M $4.522M
Total Assets $44.24M $44.24M $29.30M
YoY Change 50.97% 50.97% 34.55%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $403.0K $403.0K $272.0K
YoY Change 48.16% 48.16% -15.26%
Accrued Expenses $153.0K $2.656M $71.00K
YoY Change 115.49% 118.42% -27.55%
Deferred Revenue
YoY Change
Short-Term Debt $0.00 $0.00 $0.00
YoY Change
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities $6.193M $6.193M $3.272M
YoY Change 89.27% 89.27% 43.82%
LONG-TERM LIABILITIES
Long-Term Debt $0.00 $0.00 $0.00
YoY Change
Other Long-Term Liabilities $480.0K $483.0K $110.0K
YoY Change 336.36% 335.14%
Total Long-Term Liabilities $758.0K $483.0K $111.0K
YoY Change 582.88% 335.14%
TOTAL LIABILITIES
Total Short-Term Liabilities $6.193M $6.193M $3.272M
Total Long-Term Liabilities $758.0K $483.0K $111.0K
Total Liabilities $6.951M $6.951M $3.383M
YoY Change 105.47% 105.47% 48.7%
SHAREHOLDERS EQUITY
Retained Earnings $21.84M $10.88M
YoY Change 100.86% 134.83%
Common Stock $15.54M $15.14M
YoY Change 2.65% 1.16%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares $0.00
Shareholders Equity $37.29M $37.29M $25.92M
YoY Change
Total Liabilities & Shareholders Equity $44.24M $44.24M $29.30M
YoY Change 50.97% 50.97% 34.55%

Cashflow Statement

Concept 2019 Q4 2019 2018 Q4
OPERATING ACTIVITIES
Net Income $3.700M $10.97M $2.430M
YoY Change 52.26% 75.67% -473.85%
Depreciation, Depletion And Amortization $280.0K $1.012M $180.0K
YoY Change 55.56% 64.82% 100.0%
Cash From Operating Activities $2.910M $10.59M $1.670M
YoY Change 74.25% 59.03% -214.38%
INVESTING ACTIVITIES
Capital Expenditures $130.0K $1.676M $210.0K
YoY Change -38.1% 93.76% -54.35%
Acquisitions
YoY Change
Other Investing Activities -$120.0K -$1.621M $0.00
YoY Change 56.62% -100.0%
Cash From Investing Activities -$250.0K -$3.297M -$200.0K
YoY Change 25.0% 73.53% -79.17%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net $0.00
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities 50.00K 210.0K 80.00K
YoY Change -37.5% 89.19%
NET CHANGE
Cash From Operating Activities 2.910M 10.59M 1.670M
Cash From Investing Activities -250.0K -3.297M -200.0K
Cash From Financing Activities 50.00K 210.0K 80.00K
Net Change In Cash 2.710M 7.496M 1.550M
YoY Change 74.84% 54.02% -164.05%
FREE CASH FLOW
Cash From Operating Activities $2.910M $10.59M $1.670M
Capital Expenditures $130.0K $1.676M $210.0K
Free Cash Flow $2.780M $8.909M $1.460M
YoY Change 90.41% 53.84% -176.04%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2020 dei Amendment Flag
AmendmentFlag
false
CY2020 dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--12-31
CY2019 ins Increase Decrease In Deferred Revenue Noncurrent
IncreaseDecreaseInDeferredRevenueNoncurrent
-88000
CY2020 dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
FY
CY2020 dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2020
CY2020 dei Document Period End Date
DocumentPeriodEndDate
2020-12-31
CY2020 dei Document Type
DocumentType
10-K
CY2020 dei Entity Central Index Key
EntityCentralIndexKey
0000320340
CY2021Q1 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
8928885
CY2020 dei Entity Current Reporting Status
EntityCurrentReportingStatus
Yes
CY2020 dei Entity Emerging Growth Company
EntityEmergingGrowthCompany
false
CY2020 dei Entity Filer Category
EntityFilerCategory
Non-accelerated Filer
CY2020 dei Entity Interactive Data Current
EntityInteractiveDataCurrent
Yes
CY2020Q2 dei Entity Public Float
EntityPublicFloat
208401926
CY2020 dei Entity Registrant Name
EntityRegistrantName
INTELLIGENT SYSTEMS CORP
CY2020 dei Entity Shell Company
EntityShellCompany
false
CY2020 dei Entity Small Business
EntitySmallBusiness
true
CY2020 dei Entity Voluntary Filers
EntityVoluntaryFilers
No
CY2020 dei Entity Well Known Seasoned Issuer
EntityWellKnownSeasonedIssuer
No
CY2020 dei Security12b Title
Security12bTitle
Common Stock, $0.01 par value
CY2020 dei Trading Symbol
TradingSymbol
ins
CY2020Q4 ins Deferred Tax Asset Fixed Assets
DeferredTaxAssetFixedAssets
-1347000
CY2019Q4 ins Deferred Tax Asset Fixed Assets
DeferredTaxAssetFixedAssets
-370000
CY2020 ins Effective Income Tax Rate Reconciliation Equity Compensation Percent
EffectiveIncomeTaxRateReconciliationEquityCompensationPercent
0.003
CY2019 ins Effective Income Tax Rate Reconciliation Equity Compensation Percent
EffectiveIncomeTaxRateReconciliationEquityCompensationPercent
-0.057
CY2020 ins Increase Decrease In Deferred Revenue Current
IncreaseDecreaseInDeferredRevenueCurrent
633000
CY2019 ins Increase Decrease In Deferred Revenue Current
IncreaseDecreaseInDeferredRevenueCurrent
-92000
CY2020 ins Increase Decrease In Deferred Revenue Noncurrent
IncreaseDecreaseInDeferredRevenueNoncurrent
-23000
CY2020Q4 ins Lessee Operating Lease Liability To Be Paid After Year Four
LesseeOperatingLeaseLiabilityToBePaidAfterYearFour
108000
CY2020 ins Noncash Interest Income
NoncashInterestIncome
131000
CY2019 ins Noncash Interest Income
NoncashInterestIncome
49000
CY2020Q4 ins Notes And Interest Receivable Noncurrent
NotesAndInterestReceivableNoncurrent
2681000
CY2019Q4 ins Notes And Interest Receivable Noncurrent
NotesAndInterestReceivableNoncurrent
1795000
CY2020Q4 ins Operating Lease Rightofuse Asset And Lease Liability
OperatingLeaseRightofuseAssetAndLeaseLiability
2889000
CY2019Q4 ins Operating Lease Rightofuse Asset And Lease Liability
OperatingLeaseRightofuseAssetAndLeaseLiability
945000
CY2020 ins Payments For Notes And Interest Receivable
PaymentsForNotesAndInterestReceivable
1000000
CY2019 ins Payments For Notes And Interest Receivable
PaymentsForNotesAndInterestReceivable
2000000
CY2020Q4 us-gaap Accounts Payable Current
AccountsPayableCurrent
714000
CY2019Q4 us-gaap Accounts Payable Current
AccountsPayableCurrent
403000
CY2020Q4 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
3270000
CY2019Q4 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
8759000
CY2020Q4 us-gaap Accrued Income Taxes Current
AccruedIncomeTaxesCurrent
954000
CY2019Q4 us-gaap Accrued Income Taxes Current
AccruedIncomeTaxesCurrent
1100000
CY2020Q4 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
321000
CY2019Q4 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
153000
CY2020Q4 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
5395000
CY2019Q4 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
3322000
CY2020Q4 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
-140000
CY2019Q4 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
-94000
CY2020Q4 us-gaap Additional Paid In Capital Common Stock
AdditionalPaidInCapitalCommonStock
15836000
CY2019Q4 us-gaap Additional Paid In Capital Common Stock
AdditionalPaidInCapitalCommonStock
15450000
CY2020Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
37956000
CY2020 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
11541000
CY2019 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
191000
CY2020 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
386000
CY2020 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
386000
CY2019 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
191000
CY2020Q4 us-gaap Allowance For Doubtful Accounts Receivable Current
AllowanceForDoubtfulAccountsReceivableCurrent
0
CY2019Q4 us-gaap Allowance For Doubtful Accounts Receivable Current
AllowanceForDoubtfulAccountsReceivableCurrent
0
CY2020 us-gaap Allowance For Loan And Lease Losses Write Offs
AllowanceForLoanAndLeaseLossesWriteOffs
0
CY2019 us-gaap Allowance For Loan And Lease Losses Write Offs
AllowanceForLoanAndLeaseLossesWriteOffs
0
CY2020 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
95000
CY2019 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
95000
CY2020Q4 us-gaap Assets
Assets
57025000
CY2019Q4 us-gaap Assets
Assets
44240000
CY2020Q4 us-gaap Assets Current
AssetsCurrent
42489000
CY2019Q4 us-gaap Assets Current
AssetsCurrent
36079000
CY2020Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
37956000
CY2019Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
26415000
CY2019Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
26415000
CY2018Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
18919000
CY2019 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
7496000
CY2020Q4 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
CY2020 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
8115000
CY2019 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
10967000
CY2019Q4 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
CY2020Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.01
CY2019Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.01
CY2020Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
20000000
CY2019Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
20000000
CY2020Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
8929368
CY2019Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
8924988
CY2020Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
8885797
CY2019Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
8924988
CY2020Q4 us-gaap Common Stock Value
CommonStockValue
89000
CY2019Q4 us-gaap Common Stock Value
CommonStockValue
89000
CY2020Q4 us-gaap Cost Method Investments
CostMethodInvestments
1921000
CY2019Q4 us-gaap Cost Method Investments
CostMethodInvestments
3081000
CY2020 us-gaap Cost Of Revenue
CostOfRevenue
15427000
CY2019 us-gaap Cost Of Revenue
CostOfRevenue
11759000
CY2020 us-gaap Costmethod Investments Other Than Temporary Impairment
CostmethodInvestmentsOtherThanTemporaryImpairment
1009000
CY2019 us-gaap Costmethod Investments Other Than Temporary Impairment
CostmethodInvestmentsOtherThanTemporaryImpairment
CY2020Q4 us-gaap Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
1901000
CY2019Q4 us-gaap Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
2503000
CY2020Q4 us-gaap Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized
EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized
235000
CY2020 us-gaap Current Income Tax Expense Benefit
CurrentIncomeTaxExpenseBenefit
1925000
CY2019 us-gaap Current Income Tax Expense Benefit
CurrentIncomeTaxExpenseBenefit
1991000
CY2020 us-gaap Deferred Income Tax Expense Benefit
DeferredIncomeTaxExpenseBenefit
543000
CY2019 us-gaap Deferred Income Tax Expense Benefit
DeferredIncomeTaxExpenseBenefit
555000
CY2020Q4 us-gaap Deferred Income Tax Liabilities
DeferredIncomeTaxLiabilities
301000
CY2020Q4 us-gaap Deferred Income Tax Liabilities Net
DeferredIncomeTaxLiabilitiesNet
818000
CY2019Q4 us-gaap Deferred Income Tax Liabilities Net
DeferredIncomeTaxLiabilitiesNet
275000
CY2020Q4 us-gaap Deferred Revenue Current
DeferredRevenueCurrent
1322000
CY2019Q4 us-gaap Deferred Revenue Current
DeferredRevenueCurrent
689000
CY2020Q4 us-gaap Deferred Revenue Noncurrent
DeferredRevenueNoncurrent
CY2019Q4 us-gaap Deferred Revenue Noncurrent
DeferredRevenueNoncurrent
23000
CY2019Q4 us-gaap Deferred Tax Assets Gross
DeferredTaxAssetsGross
307000
CY2020Q4 us-gaap Deferred Tax Assets Other
DeferredTaxAssetsOther
134000
CY2019Q4 us-gaap Deferred Tax Assets Other
DeferredTaxAssetsOther
95000
CY2020Q4 us-gaap Deferred Tax Assets Tax Credit Carryforwards Foreign
DeferredTaxAssetsTaxCreditCarryforwardsForeign
124000
CY2019Q4 us-gaap Deferred Tax Assets Tax Credit Carryforwards Foreign
DeferredTaxAssetsTaxCreditCarryforwardsForeign
CY2020Q4 us-gaap Deferred Tax Assets Unrealized Losses On Availablefor Sale Securities Gross
DeferredTaxAssetsUnrealizedLossesOnAvailableforSaleSecuritiesGross
788000
CY2019Q4 us-gaap Deferred Tax Assets Unrealized Losses On Availablefor Sale Securities Gross
DeferredTaxAssetsUnrealizedLossesOnAvailableforSaleSecuritiesGross
582000
CY2020Q4 us-gaap Deferred Tax Assets Valuation Allowance
DeferredTaxAssetsValuationAllowance
517000
CY2019Q4 us-gaap Deferred Tax Assets Valuation Allowance
DeferredTaxAssetsValuationAllowance
582000
CY2020 us-gaap Defined Contribution Plan Employer Discretionary Contribution Amount
DefinedContributionPlanEmployerDiscretionaryContributionAmount
46000
CY2019 us-gaap Defined Contribution Plan Employer Discretionary Contribution Amount
DefinedContributionPlanEmployerDiscretionaryContributionAmount
41000
CY2020 us-gaap Depreciation And Amortization
DepreciationAndAmortization
2138000
CY2019 us-gaap Depreciation And Amortization
DepreciationAndAmortization
1012000
CY2020 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.91
CY2019 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
1.24
CY2020 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.91
CY2019 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
1.22
CY2020 us-gaap Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
-46000
CY2019 us-gaap Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
-2000
CY2020 us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
0.232
CY2019 us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
0.188
CY2020 us-gaap Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate
EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate
0.21
CY2019 us-gaap Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate
EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate
0.21
CY2020 us-gaap Effective Income Tax Rate Reconciliation Other Adjustments
EffectiveIncomeTaxRateReconciliationOtherAdjustments
-0.001
CY2019 us-gaap Effective Income Tax Rate Reconciliation Other Adjustments
EffectiveIncomeTaxRateReconciliationOtherAdjustments
-0.002
CY2020 us-gaap Effective Income Tax Rate Reconciliation State And Local Income Taxes
EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes
0.047
CY2019 us-gaap Effective Income Tax Rate Reconciliation State And Local Income Taxes
EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes
0.037
CY2020 us-gaap Effective Income Tax Rate Reconciliation Tax Credits Foreign
EffectiveIncomeTaxRateReconciliationTaxCreditsForeign
0.027
CY2019 us-gaap Effective Income Tax Rate Reconciliation Tax Credits Foreign
EffectiveIncomeTaxRateReconciliationTaxCreditsForeign
CY2020 us-gaap Increase Decrease In Accrued Liabilities
IncreaseDecreaseInAccruedLiabilities
168000
CY2019 us-gaap Increase Decrease In Accrued Liabilities
IncreaseDecreaseInAccruedLiabilities
82000
CY2020Q1 us-gaap Equity Method Investments
EquityMethodInvestments
0
CY2020 us-gaap Gain Loss On Sale Of Investments
GainLossOnSaleOfInvestments
125000
CY2019 us-gaap Gain Loss On Sale Of Investments
GainLossOnSaleOfInvestments
34000
CY2020 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
3866000
CY2019 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
3495000
CY2020 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
10629000
CY2019 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
13515000
CY2020 us-gaap Income Loss From Equity Method Investments
IncomeLossFromEquityMethodInvestments
-400000
CY2019 us-gaap Income Loss From Equity Method Investments
IncomeLossFromEquityMethodInvestments
-332000
CY2020 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
2468000
CY2019 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
2546000
CY2020 us-gaap Income Taxes Paid Net
IncomeTaxesPaidNet
1826000
CY2019 us-gaap Income Taxes Paid Net
IncomeTaxesPaidNet
1159000
CY2020 us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
311000
CY2019 us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
131000
CY2020 us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
-5489000
CY2019 us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
5028000
CY2020Q4 us-gaap Lessee Operating Lease Liability Payments Due Year Two
LesseeOperatingLeaseLiabilityPaymentsDueYearTwo
795000
CY2020 us-gaap Increase Decrease In Employee Related Liabilities
IncreaseDecreaseInEmployeeRelatedLiabilities
-602000
CY2019 us-gaap Increase Decrease In Employee Related Liabilities
IncreaseDecreaseInEmployeeRelatedLiabilities
1358000
CY2020 us-gaap Increase Decrease In Other Current Assets
IncreaseDecreaseInOtherCurrentAssets
358000
CY2019 us-gaap Increase Decrease In Other Current Assets
IncreaseDecreaseInOtherCurrentAssets
-224000
CY2020 us-gaap Increase Decrease In Other Current Liabilities
IncreaseDecreaseInOtherCurrentLiabilities
2945000
CY2019 us-gaap Increase Decrease In Other Current Liabilities
IncreaseDecreaseInOtherCurrentLiabilities
961000
CY2020 us-gaap Increase Decrease In Other Noncurrent Assets
IncreaseDecreaseInOtherNoncurrentAssets
-22000
CY2019 us-gaap Increase Decrease In Other Noncurrent Assets
IncreaseDecreaseInOtherNoncurrentAssets
-61000
CY2020 us-gaap Incremental Common Shares Attributable To Share Based Payment Arrangements
IncrementalCommonSharesAttributableToShareBasedPaymentArrangements
95000
CY2019 us-gaap Incremental Common Shares Attributable To Share Based Payment Arrangements
IncrementalCommonSharesAttributableToShareBasedPaymentArrangements
95000
CY2020 us-gaap Investment Income Net
InvestmentIncomeNet
-1044000
CY2019 us-gaap Investment Income Net
InvestmentIncomeNet
34000
CY2020Q4 us-gaap Lessee Operating Lease Liability Payments Due
LesseeOperatingLeaseLiabilityPaymentsDue
3099000
CY2020Q4 us-gaap Lessee Operating Lease Liability Payments Due Next Twelve Months
LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths
983000
CY2020Q4 us-gaap Lessee Operating Lease Liability Payments Due Year Four
LesseeOperatingLeaseLiabilityPaymentsDueYearFour
495000
CY2020Q4 us-gaap Lessee Operating Lease Liability Payments Due Year Three
LesseeOperatingLeaseLiabilityPaymentsDueYearThree
718000
CY2020Q4 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
3020000
CY2020Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
57025000
CY2019Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
44240000
CY2020Q4 us-gaap Liabilities Current
LiabilitiesCurrent
10062000
CY2019Q4 us-gaap Liabilities Current
LiabilitiesCurrent
6193000
CY2020Q4 us-gaap Liabilities Noncurrent
LiabilitiesNoncurrent
2812000
CY2019Q4 us-gaap Liabilities Noncurrent
LiabilitiesNoncurrent
758000
CY2020Q4 us-gaap Liability For Uncertain Tax Positions Current
LiabilityForUncertainTaxPositionsCurrent
0
CY2020Q4 us-gaap Long Term Investments
LongTermInvestments
1921000
CY2019Q4 us-gaap Long Term Investments
LongTermInvestments
3081000
CY2020 us-gaap Marketing Expense
MarketingExpense
132000
CY2019 us-gaap Marketing Expense
MarketingExpense
151000
CY2020 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
-1639000
CY2019 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
210000
CY2020 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-7740000
CY2019 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-3297000
CY2020 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
20966000
CY2019 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
10585000
CY2020 us-gaap Net Income Loss
NetIncomeLoss
8161000
CY2019 us-gaap Net Income Loss
NetIncomeLoss
10969000
CY2020 us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
8161000
CY2019 us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
10969000
CY2020 us-gaap Number Of Operating Segments
NumberOfOperatingSegments
1
CY2020 us-gaap Operating Income Loss
OperatingIncomeLoss
11295000
CY2019 us-gaap Operating Income Loss
OperatingIncomeLoss
13382000
CY2020 us-gaap Operating Lease Expense
OperatingLeaseExpense
1052000
CY2019 us-gaap Operating Lease Expense
OperatingLeaseExpense
563000
CY2020Q4 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
1994000
CY2019Q4 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
460000
CY2020 us-gaap Operating Lease Payments
OperatingLeasePayments
1033000
CY2019 us-gaap Operating Lease Payments
OperatingLeasePayments
563000
CY2020Q4 us-gaap Operating Lease Weighted Average Discount Rate Percent
OperatingLeaseWeightedAverageDiscountRatePercent
0.038
CY2019Q4 us-gaap Operating Lease Weighted Average Discount Rate Percent
OperatingLeaseWeightedAverageDiscountRatePercent
0.055
CY2020Q4 us-gaap Operating Lease Weighted Average Remaining Lease Term1
OperatingLeaseWeightedAverageRemainingLeaseTerm1
P3Y182D
CY2019Q4 us-gaap Operating Lease Weighted Average Remaining Lease Term1
OperatingLeaseWeightedAverageRemainingLeaseTerm1
P1Y36D
CY2020Q4 us-gaap Other Assets Current
OtherAssetsCurrent
1263000
CY2019Q4 us-gaap Other Assets Current
OtherAssetsCurrent
905000
CY2019Q4 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
1108000
CY2019 us-gaap Other Comprehensive Income Foreign Currency Transaction And Translation Adjustment Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent
-2000
CY2020 us-gaap Other Comprehensive Income Foreign Currency Transaction And Translation Adjustment Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent
-46000
CY2020 us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
-46000
CY2019 us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
-2000
CY2020Q4 us-gaap Other Liabilities Current
OtherLiabilitiesCurrent
4850000
CY2019Q4 us-gaap Other Liabilities Current
OtherLiabilitiesCurrent
1345000
CY2020 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
378000
CY2019 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
99000
CY2020 us-gaap Payments For Repurchase Of Common Stock
PaymentsForRepurchaseOfCommonStock
1639000
CY2019 us-gaap Payments For Repurchase Of Common Stock
PaymentsForRepurchaseOfCommonStock
CY2020 us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
6875000
CY2019 us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
1676000
CY2020 us-gaap Proceeds From Sale Of Longterm Investments
ProceedsFromSaleOfLongtermInvestments
135000
CY2019 us-gaap Proceeds From Sale Of Longterm Investments
ProceedsFromSaleOfLongtermInvestments
379000
CY2020 us-gaap Proceeds From Stock Options Exercised
ProceedsFromStockOptionsExercised
CY2019 us-gaap Proceeds From Stock Options Exercised
ProceedsFromStockOptionsExercised
210000
CY2020 us-gaap Profit Loss
ProfitLoss
8161000
CY2019 us-gaap Profit Loss
ProfitLoss
10969000
CY2020Q4 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
12309000
CY2019Q4 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
5499000
CY2020Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
6914000
CY2019Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
2177000
CY2020 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
5153000
CY2019 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
5516000
CY2020Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
30005000
CY2019Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
21844000
CY2020 us-gaap Revenue From Contract With Customer Including Assessed Tax
RevenueFromContractWithCustomerIncludingAssessedTax
35873000
CY2019 us-gaap Revenue From Contract With Customer Including Assessed Tax
RevenueFromContractWithCustomerIncludingAssessedTax
34303000
CY2020 us-gaap Share Based Compensation
ShareBasedCompensation
386000
CY2019 us-gaap Share Based Compensation
ShareBasedCompensation
191000
CY2019 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate
0
CY2019 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate
0.51
CY2019 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate
0.0258
CY2020Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Number Of Shares Available For Grant
ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant
885620
CY2019Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Number Of Shares Available For Grant
ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant
763000
CY2020Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber
102500
CY2019Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber
84500
CY2020Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice
5.61
CY2019Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice
2.21
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures And Expirations In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod
282680
CY2020 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures And Expirations In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod
CY2019 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures And Expirations In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod
16000
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross
1356500
CY2020 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross
CY2019 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross
42000
CY2019 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
16.15
CY2019Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
126500
CY2018Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
207500
CY2020Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
126500
CY2020Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber
24000
CY2020 us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Exercises In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice
CY2019 us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Exercises In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice
1.97
CY2020 us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice
CY2019 us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice
25.45
CY2020 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Fair Value Assumptions Expected Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1
P10Y
CY2019 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Fair Value Assumptions Expected Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1
P10Y
CY2020Q4 us-gaap Sharebased Compensation Shares Authorized Under Stock Option Plans Exercise Price Range Outstanding Options Weighted Average Exercise Price Beginning Balance1
SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageExercisePriceBeginningBalance1
8.94
CY2019Q4 us-gaap Sharebased Compensation Shares Authorized Under Stock Option Plans Exercise Price Range Outstanding Options Weighted Average Exercise Price Beginning Balance1
SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageExercisePriceBeginningBalance1
8.94
us-gaap Stock Issued During Period Shares Stock Options Exercised
StockIssuedDuringPeriodSharesStockOptionsExercised
947320
CY2020 us-gaap Stock Issued During Period Shares Stock Options Exercised
StockIssuedDuringPeriodSharesStockOptionsExercised
CY2019 us-gaap Stock Issued During Period Shares Stock Options Exercised
StockIssuedDuringPeriodSharesStockOptionsExercised
107000
CY2019 us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
210000
CY2020Q4 us-gaap Stock Repurchase Program Authorized Amount1
StockRepurchaseProgramAuthorizedAmount1
3361000
CY2020Q4 us-gaap Stockholders Equity
StockholdersEquity
44151000
CY2019Q4 us-gaap Stockholders Equity
StockholdersEquity
37289000
CY2018Q4 us-gaap Stockholders Equity
StockholdersEquity
25921000
CY2020Q4 us-gaap Treasury Stock Shares
TreasuryStockShares
43571
CY2019Q4 us-gaap Treasury Stock Shares
TreasuryStockShares
0
CY2020Q4 us-gaap Treasury Stock Value
TreasuryStockValue
1639000
CY2019Q4 us-gaap Treasury Stock Value
TreasuryStockValue
CY2020 us-gaap Treasury Stock Value Acquired Cost Method
TreasuryStockValueAcquiredCostMethod
1639000
CY2020Q4 us-gaap Unrecognized Tax Benefits
UnrecognizedTaxBenefits
0
CY2019Q4 us-gaap Unrecognized Tax Benefits
UnrecognizedTaxBenefits
0
CY2020Q4 us-gaap Unrecognized Tax Benefits Income Tax Penalties And Interest Accrued
UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued
0
CY2020 us-gaap Use Of Estimates
UseOfEstimates
<div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt">Use of Estimates</div><div style="display: inline; font-style: italic;"> </div>&#x2013; In preparing the financial statements in conformity with accounting principles generally accepted in the United States, management makes estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements. These estimates and assumptions also affect amounts of revenues and expenses during the reporting periods. Actual results could differ from these estimates. Areas where we use estimates and make assumptions are to determine our allowance for doubtful accounts, valuation of our investments, depreciation and amortization expense, accrued expenses and deferred income taxes.</div></div></div></div></div></div></div></div></div></div></div></div></div></div></div>
CY2020 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
9014985
CY2019 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
8967901
CY2020 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
8919602
CY2019 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
8873071

Files In Submission

Name View Source Status
0001437749-21-004982-index-headers.html Edgar Link pending
0001437749-21-004982-index.html Edgar Link pending
0001437749-21-004982.txt Edgar Link pending
0001437749-21-004982-xbrl.zip Edgar Link pending
ex_229525.htm Edgar Link pending
ex_229526.htm Edgar Link pending
ex_229527.htm Edgar Link pending
ex_229528.htm Edgar Link pending
ex_229529.htm Edgar Link pending
ex_229530.htm Edgar Link pending
FilingSummary.xml Edgar Link unprocessable
Financial_Report.xlsx Edgar Link pending
ins-20201231.xml Edgar Link completed
ins-20201231.xsd Edgar Link pending
ins-20201231_cal.xml Edgar Link unprocessable
ins-20201231_def.xml Edgar Link unprocessable
ins-20201231_lab.xml Edgar Link unprocessable
ins-20201231_pre.xml Edgar Link unprocessable
ins20201231_10k.htm Edgar Link pending
ins20201231_10kimg001.gif Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R39.htm Edgar Link pending
R4.htm Edgar Link pending
R40.htm Edgar Link pending
R41.htm Edgar Link pending
R42.htm Edgar Link pending
R43.htm Edgar Link pending
R44.htm Edgar Link pending
R45.htm Edgar Link pending
R46.htm Edgar Link pending
R47.htm Edgar Link pending
R48.htm Edgar Link pending
R49.htm Edgar Link pending
R5.htm Edgar Link pending
R50.htm Edgar Link pending
R51.htm Edgar Link pending
R52.htm Edgar Link pending
R6.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending